Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Mar 25;95(12):e3194. doi: 10.1097/MD.0000000000003194

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0

PMC Copyright notice

Serum BAFF and IP-10 levels in patients with or without advanced fibrosis (F3 or more). (A) The median BAFF levels (range) in patients with or without advanced fibrosis (F3 or more) are: 1657.5 pg/mL (359.0–7696.0 pg/mL) in patients with advanced fibrosis and 1276.0 pg/mL (122.5–5681.5 pg/mL) in patients without advanced fibrosis (P = 0.039). (B) The median IP-10 levels (range) in patients with or without advanced fibrosis (F3 or more) are: 722.3 pg/mL (172.7–2317.4 pg/mL) in patients with advanced fibrosis and 614.3 pg/mL (142.0–4198.7 pg/mL) in patients without advanced fibrosis (P = 0.551). BAFF = B-cell activating factor belonging to the tumor necrosis factor family, IP-10 = interferon-γ-inducible protein-10.